117 related articles for article (PubMed ID: 2632072)
21. Inhibition of proliferation and induction of differentiation of human and mouse myeloid leukemia cells by new ethyleneglycol-type nonphosphorus alkyl ether lipids.
Kasukabe T; Honma Y; Hozumi M; Nomura H
Jpn J Cancer Res; 1990 Aug; 81(8):807-12. PubMed ID: 2118893
[TBL] [Abstract][Full Text] [Related]
22. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
[TBL] [Abstract][Full Text] [Related]
23. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
Civoli F; Daniel LW
Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
[TBL] [Abstract][Full Text] [Related]
24. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
25. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
26. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
[TBL] [Abstract][Full Text] [Related]
27. 1-O-benzyl-2-O-methyl-rac-glycerol: a key intermediate for synthesis of ether glycerolipids.
Pinchuk AN; Mitsner BI; Shvets VI
Chem Phys Lipids; 1991 Oct; 59(3):263-5. PubMed ID: 1804570
[TBL] [Abstract][Full Text] [Related]
28. Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience.
Berdel WE
Lipids; 1987 Nov; 22(11):970-3. PubMed ID: 3328030
[TBL] [Abstract][Full Text] [Related]
29. Conversion of alkylacetylglycerol to platelet-activating factor in HL-60 cells and subcellular localization of the mediator.
Vallari DS; Record M; Snyder F
Arch Biochem Biophys; 1990 Feb; 276(2):538-45. PubMed ID: 2154953
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of a polysaccharide fraction extracted from cultured fruiting bodies of Grifola frondosa.
Suzuki I; Itani T; Ohno N; Oikawa S; Sato K; Miyazaki T; Yadomae T
J Pharmacobiodyn; 1984 Jul; 7(7):492-500. PubMed ID: 6491867
[TBL] [Abstract][Full Text] [Related]
31. Undifferentiated HL-60 cells internalize an antitumor alkyl ether phospholipid more rapidly than resistant K562 cells.
Tsutsumi T; Tokumura A; Kitazawa S
Biochim Biophys Acta; 1998 Feb; 1390(1):73-84. PubMed ID: 9487142
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
Fos E; Suesa N; Borras L; Lobato C; Banfi P; Gambetta RA; Zunino F; Mauleón D; Carganico G
J Med Chem; 1995 Mar; 38(7):1216-28. PubMed ID: 7707324
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives. III. Synthesis and antitumor activity of 3-phenylpiperazinyl-1-trans-propenes.
Naito H; Ohsuki S; Atsumi R; Minami M; Mochizuki M; Hirotani K; Kumazawa E; Ejima A
Chem Pharm Bull (Tokyo); 2005 Feb; 53(2):153-63. PubMed ID: 15684512
[TBL] [Abstract][Full Text] [Related]
34. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
Dive C; Watson JV; Workman P
Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
[TBL] [Abstract][Full Text] [Related]
35. Syntheses and antitumor activities of N6,N6-dimethyladenosine carboxylate analogues.
Takamura T; Kato T; Arakawa E; Ogawa S; Suzumura Y; Kato T
Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2828-31. PubMed ID: 2611944
[TBL] [Abstract][Full Text] [Related]
36. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
[TBL] [Abstract][Full Text] [Related]
37. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
[TBL] [Abstract][Full Text] [Related]
39. Studies of the antitumor activity of (2-alkoxyalkyl)- and (2-alkoxyalkenyl)phosphocholines.
Bonjouklian R; Phillips ML; Kuhler KM; Grindey GB; Poore GA; Schultz RM; Altom MG
J Med Chem; 1986 Dec; 29(12):2472-7. PubMed ID: 3783607
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and hypolipidemic activity of some new esters of glycerol and 2-O-methyl-glycerol with nicotinic and 5-fluoro-nicotinic acids.
Dall'Asta L; Comini A; Borella F; Berti MA; Coppi G
Boll Chim Farm; 1989 Mar; 128(3):106-10. PubMed ID: 2775523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
